Interestingly, in contrast to the transcriptional silencing associated with full mutation expansion in FXS, FMR1 mRNA is transcriptionally upregulated by 2–8-fold in patients with FXTAS in comparison to healthy controls (Tassone et al., 2000; 2007). The gene discussed is FMR1; the disease is fragile X syndrome.